EGFR and lung carcinoma: Strikingly, iRhom2D188N also further increased spheroid growth compared to iRhom2WT (Fig. 6C), demonstrating that even in transformed A549 cells, the elevated release of ERBB ligand caused by the tylotic iRhom2 mutation is sufficient to further promote spheroid growth of lung cancer cells.